$SNEX

StoneX Group (SNEX) Could Be 57% Undervalued After Strong Q3 Results

Simply Wall St highlights StoneX Group (SNEX) after its Aug. 5 Q3 and year-to-date results showed higher revenue, net income, and EPS versus the prior year. The stock fell recently, but remains up YTD. A narrative model estimates fair value at $155 versus a $65.97 close, while a DCF suggests $22.08.

Original reporting
Published Aug 12, 2026, 8:44 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 12:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$SNEX
Neutral
medium confidence
Mentioned
$SNEX
Relevance
4/10
alphai data visualization · based on simplywall.st
Decision brief

The 30-second read

$SNEXNeutralLow
01

Why it matters

The article contrasts a narrative fair value estimate ($155) with a DCF cash-flow estimate ($22.08), but it does not introduce new company-specific disclosures such as updated guidance, new contract terms, or regulatory actions.

02

Market read

Valuation debate and post-earnings sentiment framing may attract attention, but the trading decision is likely driven by the underlying Aug. 5 results rather than this promotional valuation comparison.

03

What to watch

The piece flags risks like integration costs or client churn, but does not quantify them, so traders should verify margin and client retention details from the Aug. 5 filing/call.

Relevance 4/10Novelty 3/10Timing: post-earnings framing after Aug. 5 Q3 results and recent pullback

Background

StoneX Group is discussed as a larger futures commission merchant after the July 2025 R.J. O’Brien acquisition, with attention on Q3 performance and payments partnership news.

Company-level read

Ticker impact

$SNEXNeutralMedium confidence
Context

Simply Wall St highlights StoneX’s Aug. 5 Q3 results with higher revenue, net income, and EPS, plus valuation debate after the pullback.

Expected impact

Limited near-term impact from this piece alone; any trading reaction would depend on the underlying Aug. 5 results and integration updates, not the DCF vs narrative comparison.

Evidence & confidence

The newest concrete facts in the text are the existence of Q3 outperformance and the R.J. O’Brien acquisition being completed in July 2025, but the article does not add fresh numbers, guidance, or incremental disclosures beyond those references.

Market effects

Could modestly influence sentiment toward listed derivatives and commodity brokerage intermediaries, but the article does not disclose sector-wide new data.

No specific regional market catalyst is provided.

No direct global macro or cross-border policy change is disclosed.

Counterpoint

The DCF lens in the article suggests SNEX may be overvalued versus a cash-flow estimate, implying the “57% undervalued” narrative could be overstated.

Key entities

  • StoneX Group

    Subject of the article, discussed in relation to Aug. 5 Q3 results, valuation narratives, and the R.J. O’Brien acquisition.

  • R.J. O’Brien acquisition

    Completed in July 2025, described as strengthening StoneX’s derivatives, clearing, and commodity brokerage franchise.

Related articles

MedAI 8/10

Homerun Resources Inc.: Homerun Resources Inc. Announces Closing of Initial Tranche of Convertible Security Financing with the Lind Partners Under Engagements with Benchmark/StoneX

Homerun Resources Inc. (TSXV:HMR, OTCQB:HMRFF) closed a C$2.0 million initial tranche of a convertible security financing with Lind Global Fund III, LP, managed by The Lind Partners, under a CSFA. The convertible has a 24-month term, C$0.66 conversion price, 1,850,000 warrants, and a six-month repayment holiday, with monthly repayments thereafter. Benchmark (StoneX subsidiary) received fees and shares.

$SNEXMedAI 8/10

StoneX (SNEX) Q3 2026 Earnings Call Transcript

StoneX Group Inc. (SNEX) reported Q3 FY2026 net operating revenues of $719.7 million, up 47% year over year, and net income of $127.9 million, up 102%. Diluted EPS was $1.00, up 85% after a 3-for-2 stock split. Segment results cited growth from R.J. O’Brien and The Benchmark acquisitions, plus a Shinhan Bank partnership.

$SNEXMed

StoneX Agrees to Buy Banco Travelex in Brazil, Pending Central Bank Approval

StoneX Group Inc. (NASDAQ: SNEX) said it agreed to buy Banco Travelex S.A. in Brazil for an undisclosed price, pending Central Bank of Brazil approval and other closing conditions. StoneX expects the deal to close in about 12 months and said it will expand Brazil payments and FX services, including non-resident accounts and PIX. Travelex Confidence retail FX stores are excluded.